Treatment of Periodontitis via Recruitment of Regulatory Lymphocytes
Treatment of Periodontitis via Recruitment of Regulatory Lymphocytes
批准号:
8522273
负责人:
STEVEN R LITTLE
金额:
$33.99万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-08-31
关键词:
AddressAffectAlveolar Bone LossAmericanAntibioticsAntibodiesBiologicalBone ResorptionCCL22 geneCalculiCardiovascular DiseasesCellsChemotactic FactorsChemotaxisDataDebridementDegenerative polyarthritisDevelopmentDiabetes MellitusDiseaseDisorder by SiteDrug FormulationsEffectivenessEngineeringEnvironmentFutureGene ExpressionGene Expression ProfilingGlucocorticoidsGlycolatesGrowthHomeostasisImmuneImmune System DiseasesImmune responseIn SituIn VitroIncidenceInfectionInflammationInflammation MediatorsInflammatoryInjection of therapeutic agentKidney DiseasesLaboratoriesLeadLesionLigamentsLung diseasesLymphocyteLymphocyte SubsetMediatingMetabolismMinocyclineModelingMonitorMusNatural regenerationOral healthPathologyPatientsPeriodontal DiseasesPeriodontitisPeriodontiumPhysiologicalPlayPopulationPremature BirthProcessProliferatingProteinsPublic HealthRecruitment ActivityRegulationRegulatory T-LymphocyteResolutionRoleSymptomsSystemic infectionT-LymphocyteTemporomandibular JointTestingTherapeuticTimeTissuesTooth LossTreatment FactorTumor Necrosis Factor ReceptorWorkbonechemokinecontrolled releasecytokinedesignimprovedkillingslymph nodesmigrationmolecular markermouse modelpathogenpredictive modelingprematurereceptorresidenceresponsesoft tissuestandard of care
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It is becoming clear that periodontitis is not only characterized by pathogenic infection, but even more so by a loss of immunological homeostasis. Strategies toward resolution of regenerating the periodontium without completely blocking immune responses against local and systemic infections would be ideal. Our long-term objective is to address the physiological cause of periodontitis through an understanding of the inflammatory and regulatory processes of the periodontium. Correspondingly, recent data in our laboratories indicate that periodontitis symptoms are accompanied by the absence of an important cell subset called regulatory T-cells. We hypothesize that controlled release formulations of Treg-recruiting factors is a viable way to regenerate the periodontal space. This hypothesis is supported by our preliminary data demonstrating that controlled release of Treg recruiting factors leads to an increase in regulatory T-cells in the periodontium, in the draining lymph nodes, and, consequently, resolution of periodontal disease symptoms 2 mouse models. Specific Aim I: To engineer controlled release formulations that can influence the number of Tregs in the periodontium and abrogation of the symptoms of periodontitis. We will rationally design and fabricate controlled release microparticles to produce various release profiles of Treg recruiting factors and then examine their effect on alveolar bone loss using two different murine models of periodontal disease. Furthermore, we will explore the expansion of local lymphocytes toward an enriched population of Tregs through controlled release of a combination of several key molecules. Specific Aim II: To better understand the biological mechanisms of Treg recruitment and function in periodontal tissues. We will examine the mechanisms of Treg chemotaxis in the periodontium by monitoring gene expression in response to Treg recruiting therapies and chemotaxis in mice deficient in receptors thought to be important for migration and function of Tregs. We will then investigate the duration of Treg residence in the periodontium under inflammatory conditions after a single injection of our preliminary CCL22 microparticle formulations. We will also examine the expression levels of molecular markers associated with Tregs and tissue metabolism to elucidate the mechanisms of Treg-mediated periodontal disease abrogation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combined Hydrogel/Microparticle Eye Drops for Sustained Delivery of Glaucoma Medication
-
批准号:9186545
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2014
-
负责人:STEVEN R LITTLE
-
依托单位:
Combined Hydrogel/Microparticle Eye Drops for Sustained Delivery of Glaucoma Medication
-
批准号:8817604
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2014
-
负责人:STEVEN R LITTLE
-
依托单位:
Treatment of Periodontitis via Recruitment of Regulatory Lymphocytes
-
批准号:8321474
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2011
-
负责人:STEVEN R LITTLE
-
依托单位:
Treatment of Periodontitis via Recruitment of Regulatory Lymphocytes
-
批准号:8723640
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2011
-
负责人:STEVEN R LITTLE
-
依托单位:
Treatment of Periodontitis via Recruitment of Regulatory Lymphocytes
-
批准号:8108000
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2011
-
负责人:STEVEN R LITTLE
-
依托单位:
Resolution and Regeneration in Periodontitis via Recruitment of Regulatory Lympho
-
批准号:8112200
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2010
-
负责人:STEVEN R LITTLE
-
依托单位:
海外基金